AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Indianapolis-based Roche Diagnostics announced last month that it received Food and Drug Administration clearance to begin marketing ONTRAK TESTCUP-er, a drug testing device that will assess the drug use status of emergency-room patients. In less than five minutes, the test can simultaneously detect cocaine, morphine, amphetamines, barbiturates and benzodiazepines, according to a company statement. This information can be critical for treating …